AGP Executive Report
Last update: 5 hours agoDrug Pricing: A 45-state coalition settled with Ascend, Citron and Mayne Pharma over alleged generic-drug price manipulation; Ascend will pay $400,000 and Mayne $650,000, while broader litigation continues. Biopharma Deals: Galderma agreed to buy skincare brand ZO Skin Health for $1.5 billion, while Zealand Pharma and Generate Biomedicines struck an AI-driven obesity-drug deal worth up to $1.2 billion. Diagnostics: Cyted Health reported 90% sensitivity and 86% specificity in a 324-person study of its non-endoscopic Barrett’s esophagus test, which could help identify patients for follow-up endoscopy. Health Data: A reported Oracle Health breach affected more than 20 million patients, underscoring the scale of cybersecurity risks for providers. Public Health Tech: Verily won a renewed CDC contract to support wastewater surveillance, including pathogen testing and genomic sequencing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
